Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism κ opioid receptor agonists(Kappa opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | - | 27 Oct 2026 | |
| Autoimmune Diseases | Discovery | - | 27 Oct 2026 | |
| Mood Disorders | Discovery | - | 27 Oct 2026 | |
| Mood Disorders | Discovery | - | 27 Oct 2026 | |
| Other Diseases | Discovery | - | 27 Oct 2026 | |
| Other Diseases | Discovery | - | 27 Oct 2026 | |
| Pruritus | Discovery | - | 27 Oct 2026 | |
| Pruritus | Discovery | - | 27 Oct 2026 |





